aztreonam has been researched along with Birth Weight in 3 studies
Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
Birth Weight: The mass or quantity of heaviness of an individual at BIRTH. It is expressed by units of pounds or kilograms.
Excerpt | Relevance | Reference |
---|---|---|
"Aztreonam (30 mg/kg of body weight) was administered intravenously over 3 min every 12 h to 30 preterm neonates divided into two groups according to gestational age (mean age for group A was less than 30 weeks and mean age for group B was greater than 30 weeks) and birth weight (mean weight for group A was less than 1,500 g and mean weight for group B was greater than 1,500 g)." | 3.68 | Pharmacokinetics and renal tolerance of aztreonam in premature infants. ( Benoni, G; Cuzzolin, L; Fanos, V; Padovani, EM; Zambreri, D, 1991) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sklavunu-Tsurutsoglu, S | 1 |
Gatzola-Karaveli, M | 1 |
Hatziioannidis, K | 1 |
Tsurutsoglu, G | 1 |
Cuzzolin, L | 1 |
Fanos, V | 1 |
Zambreri, D | 1 |
Padovani, EM | 1 |
Benoni, G | 1 |
Fuji, R | 1 |
Hashira, S | 1 |
Tajima, T | 1 |
Meguro, H | 1 |
Abe, T | 1 |
Sakata, H | 1 |
Kakehashi, H | 1 |
Fujita, K | 1 |
Murono, K | 1 |
Kaeriyama, M | 1 |
1 trial available for aztreonam and Birth Weight
Article | Year |
---|---|
[Pharmacokinetics and clinical studies on aztreonam in neonates and premature infants (the first report). Study on effectiveness and safety in mono-therapy with aztreonam. A study of aztreonam in the Perinatal Co-research Group].
Topics: Age Factors; Aztreonam; Bacterial Infections; Birth Weight; Clinical Trials as Topic; Female; Half-L | 1990 |
2 other studies available for aztreonam and Birth Weight
Article | Year |
---|---|
Aztreonam treatment of neonatal sepsis.
Topics: Anti-Bacterial Agents; Aztreonam; Birth Weight; Gram-Negative Bacterial Infections; Humans; Infant; | 1989 |
Pharmacokinetics and renal tolerance of aztreonam in premature infants.
Topics: Acetylglucosaminidase; Aging; Aztreonam; Birth Weight; Gestational Age; Half-Life; Humans; Infant, N | 1991 |